ACMAT Corporation
ACMTA
$29.05
$0.000.00%
| Weiss Ratings | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.06 | |||
| Price History | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -13.28% | |||
| 2-Year Total Return | -13.28% | |||
| 3-Year Total Return | -17.00% | |||
| 5-Year Total Return | -6.29% | |||
| 52-Week High % Change | -3.17% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $30.00 | |||
| 52-Week Low Price | $29.05 | |||
| 52-Week Low Price (Date) | Jul 02, 2024 | |||
| 52-Week High Price (Date) | Jul 02, 2024 | |||
| Valuation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.10M | |||
| Enterprise Value | 30.50M | |||
| Price/Earnings (TTM) | 11.26 | |||
| Earnings Per Share (TTM) | 2.58 | |||
| Earnings Per Share Growth | -322.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.68 | |||
| Price/Book (Q) | 0.75 | |||
| Enterprise Value/Revenue (TTM) | 7.73 | |||
| Price | $29.05 | |||
| Enterprise Value/EBITDA (TTM) | 14.86 | |||
| Enterprise Value/EBIT | 16.36 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 771.10K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 860 415 8400 | |||
| Address | 30 South Road Farmington, CT 06032-2418 | |||
| Website | www.acmatcorp.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 47.26% | |||
| Profit Margin | 50.46% | |||
| Management Effectiveness | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.21% | |||
| Return on Equity | 7.13% | |||
| Income Statement | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.18M | |||
| Total Revenue (TTM) | 3.94M | |||
| Revenue Per Share | $5.12 | |||
| Gross Profit (TTM) | 4.69M | |||
| EBITDA (TTM) | 2.05M | |||
| EBIT (TTM) | 1.86M | |||
| Net Income (TTM) | 1.99M | |||
| Net Income Avl. to Common (TTM) | 1.99M | |||
| Total Revenue Growth (Q YOY) | 237.30% | |||
| Earnings Growth (Q YOY) | 317.62% | |||
| EPS Diluted (TTM) | 2.58 | |||
| EPS Diluted Growth (Q YOY) | 317.69% | |||
| Balance Sheet | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.06M | |||
| Cash Per Share (Q) | $9.16 | |||
| Total Current Assets (Q) | 8.51M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 29.78M | |||
| Current Ratio (Q) | 4.863 | |||
| Book Value Per Share (Q) | $38.62 | |||
| Total Assets (Q) | 56.80M | |||
| Total Current Liabilities (Q) | 1.75M | |||
| Total Debt (Q) | 2.48M | |||
| Total Liabilities (Q) | 27.01M | |||
| Total Common Equity (Q) | 29.78M | |||
| Cash Flow | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.59M | |||
| Cash from Financing (TTM) | -13.50K | |||
| Net Change in Cash (TTM) | 34.60K | |||
| Levered Free Cash Flow (TTM) | 1.34M | |||
| Cash from Operations (TTM) | 2.64M | |||
